- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Lauren Harner Considers the Challenge of Measuring Primary Nonadherence
One of the biggest challenges with measuring primary medication nonadherence is coming up with a definition for it in the first place.
One of the biggest challenges with measuring primary medication nonadherence is coming up with a definition for it in the first place. Primary nonadherence might be very different depending on the condition, explained Lauren Harner, JD, senior manager of policy at PhRMA.
Transcript (slightly modified for readability)
What are some of the challenges with quality measures related to primary medication nonadherence?
I think even defining what primary nonadherence is is a problem in developing the measure. How many days out does a patient have to be or how many days late does a patient have to be in picking up their prescription before they're "nonadherent"?
For some acute conditions, I think, 5 or 7 days you could deem the person nonadherent. But there are other types of medications where a patient could not pick it up for 30 days and I think that would be fine. So I think there are some very basic problems with measuring but I think we have to start with defining what nonadherence is.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
